New world for users and brands as ads hit AI chatbots

Weather - Sydney 10°C

New world for users and brands as ads hit AI chatbots

ECONOMY 15.02.2026

New world for users and brands as ads hit AI chatbots / Photo: © AFP/File

The introduction of advertisements and sponsored content in chatbots has spawned privacy concerns for AI users as brands scramble to stay relevant in a fast-changing online environment.

Change text size:

ChatGPT developer OpenAI began showing ads in chatbot conversations for free and low-cost users to start balancing its hundreds of billions in spending commitments with new revenue sources.

It swiftly came in for mockery from rival Anthropic, which has staked its reputation on safety and data security.

Anthropic's advertisement broadcast during last week's Super Bowl showed a man asking advice from a conversational AI, which then shoehorns advertising copy for a dating site into its otherwise relevant response.

OpenAI boss Sam Altman shot back that the clip was "clearly dishonest".

Beyond OpenAI, Microsoft has been running contextual ads and sponsored content in its Copilot AI assistant since 2023.

AI search engine Perplexity has been testing ads in the United States since 2024, while Google is also testing ads in the AI "overviews" its namesake search engine has been offering since last year.

- Data privacy -

Google has repeatedly denied wanting to run ads in its Gemini chatbot, with Demis Hassabis -- head of the search giant's DeepMind AI arm -- saying that ads "have to be handled very carefully".

"The most important thing" in AI is "trust in security and privacy, because you want to share potentially your life with that assistant," he added.

OpenAI has sought to reassure users that ChatGPT's responses will not be modified by the ads, which are shown alongside conversations rather than being integrated into them.

It has also promised not to sell user data to advertisers.

AI companies are "concerned that selling ads will scare away users," said Nate Elliott, an analyst with US data firm Emarketer.

But "when it's free, you're the product. It's a risk we're all more or less aware of already," said Jerome Malzac of AI consultancy Micropole.

"We accept it because we find value in it."

If that proves true, advertisers will be delighted to surf the AI wave as it crashes over the world's internet users.

- Game changer -

"It's going to be a game changer for the entire industry," said Justin Seibert, head of Direct Online Marketing.

"We're already seeing how high the conversion rates (interactions resulting in a purchase) are for people that are coming in from ChatGPT and the other LLMs (large language models)," he added.

AI assistants could account for up to two percent of the online advertising market by 2030, HSBC bank analysts suggested in a report.

Many brands are already prioritising visibility on the new channel, including US supermarket chain Target and software maker Adobe.

Beyond buying a spot on users' screens, companies are also pushing for their products to appear in chatbots' organic responses.

The practice is known as GEO (Generative Engine Optimisation) -- an evolution of the Search Engine Optimisation strategy during the era of Google's dominance over the web.

"We identified 90 rules that can make sure the content you create is valued by AI and spread to the right places," said Joan Burkovic, head of French GEO startup GetMint.

The company already claims 100 clients, including fashion brand Lacoste.

Malzac highlighted techniques like including references to scientific papers, adding a "frequently asked questions" section to your website, and posting information that's structured and regularly updated, Malzac said.

"If your brand isn't referenced (by chatbots) it no longer exists" for some users, he warned.

G.Waters--TNT

Featured

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

Change text size:

The National Times - New world for users and brands as ads hit AI chatbots